Macrophages activated in vitro with lymphocyte mediators kill neoplastic but not normal cells.
about
Stimulation of macrophage protease secretion via liposomal delivery of muramyl dipeptide derivatives to intracellular sitesEffects of BCG infection on the susceptibility of mouse macrophages to endotoxinCytotoxicity of rat macrophages activated by persistent or biodegradable bacterial cell walls.Tuberculin hypersensitivity hepatitis in mice infected with Mycobacterium bovis (BCG).Characterization of three macrophage chemotactic factors from PPD-induced delayed hypersensitivity reaction sites in guinea pigs, with special reference to a chemotactic lymphokineModulation of macrophage tumoricidal capability by polyene antibiotics: support for membrane lipid as a regulatory determinant of macrophage functionDifferential arginine dependence and the selective cytotoxic effects of activated macrophages for malignant cells in vitro.Thymectomy and asbestos-induced mesotheliomas in ratsMechanisms of tumor immunity. An overview.Functional characterization of a stable, noncytolytic stage of macrophage activation in tumors.Extracellular cytolysis by activated macrophages and granulocytes. I. Pharmacologic triggering of effector cells and the release of hydrogen peroxide.Alteration of some functional and metabolic characteristics of resident mouse peritoneal macrophages by lymphocyte mediators.Nonspecific resistance to bacterial infections. Enhancement by ubiquinone-8.Augmentation of macrophage complement receptor function in vitro. I. Characterization of the cellular interactions required for the generation of a T-lymphocyte product that enhances macrophage complement receptor function.Macrophage oxygen-dependent antimicrobial activity. III. Enhanced oxidative metabolism as an expression of macrophage activationLeukocyte subpopulations elicited by a nontumorigenic variant of B16 melanoma: their role in direct rejection of the melanoma and in prevention of tumorigenesis in Winn assays.Differential stimulation of murine lymphoma growth in vitro by normal and BCG-activated macrophagesOntogeny of murine macrophages: functions related to antigen presentationCandida mannan: chemistry, suppression of cell-mediated immunity, and possible mechanisms of action.Cytotoxicity of human macrophages for tumor cells. Enhancement by human lymphocyte mediators.Isolation and functional characterization of human intestinal mucosal lymphoid cells.Recombinant human migration inhibitory factor has adjuvant activity.Modulation of plasminogen activator secretion by activated macrophages: influence of serum factors and correlation with tumoricidal potential.Physicochemical characterization of cytostatic factors released from human monocytes.Activated macrophages release a factor which lyses malignant cells but not normal cellsInteractions between human monocytes and tumour cells. Monocytes can either enhance or inhibit the growth and survival of K562 cells.Differences in tumour necrosis factor productive ability among rodents.Letter: Surveillance against neoplastic cells-is it mediated by macrophages?Identification of a T cell hybridoma that produces large quantities of macrophage-activating factor.
P2860
Q28366436-3A2A4BDC-0E09-4FD9-9E5E-1FD5BD1695A8Q34081411-7B38ECF9-98D3-442D-8256-29010932B268Q34414622-C68A6A94-19C1-4BED-93F1-E754521EA1ECQ35864190-AD078BB2-2DB2-43CB-8932-11636D68B1C6Q35885167-49008EA0-7FFC-4CA8-AD7C-7BF384808DC2Q35990667-AC9D0BDE-EB84-4E67-B4A9-5FE6F9DE715EQ36042796-73977DFD-8941-44CA-AE5C-5A42AF832576Q36042918-F351A644-E7B3-4956-8B61-B0A51F648E69Q36058889-921098E3-D29E-4577-B397-DB51C1A2C830Q36337208-241D6148-9649-476F-B44B-63F881587615Q36341096-87A4AC79-D9A0-4910-94FA-B0B0D3ABB85FQ36341862-6E791D1D-1DB3-4C1F-B1D6-BF41AC0423BDQ36342080-6F7628DB-0392-4780-81CF-87FFA32E5D68Q36342834-CA78B3FA-8904-49E8-8A76-51EE4D447558Q36344298-D44E9709-4771-4FCD-B04D-4B01E2CA527BQ36347227-D2B4CAA3-87C1-471A-A35D-DA78E122B3AEQ36358479-332D00C8-6587-435B-8126-045D48119B95Q36439323-4A228881-8D93-45B3-81F7-7BF4213977E0Q36636840-B8DDEA33-AD51-41AC-9304-E5886C85D4E2Q37038190-49FE2ADE-5F0B-4187-B86A-310F74DA11B8Q37044471-7443421D-518B-4F4D-9AD4-BC5C514A0253Q37175910-7BBC5BE6-6605-4E74-A563-9E3184CEBC3FQ37339926-4CF907C9-D057-4215-9AEF-2DB2B852A72BQ40598737-4D01A5E2-D696-4775-8410-7DC768645CE3Q41959520-A9E046E4-1C4D-4BFF-81F1-9175B36402FBQ42015330-D63DFE0B-B526-4636-A10F-3D73DFD1A786Q42282043-4EB2844A-2811-4F2A-BD6E-D251237D5EE5Q42578012-071F0F22-FFEC-4A20-9413-5561F038BE1DQ42936274-B110C529-3D82-4EBD-9CCF-6B1A2353BC0B
P2860
Macrophages activated in vitro with lymphocyte mediators kill neoplastic but not normal cells.
description
1975 nî lūn-bûn
@nan
1975年の論文
@ja
1975年学术文章
@wuu
1975年学术文章
@zh-cn
1975年学术文章
@zh-hans
1975年学术文章
@zh-my
1975年学术文章
@zh-sg
1975年學術文章
@yue
1975年學術文章
@zh
1975年學術文章
@zh-hant
name
Macrophages activated in vitro ...... oplastic but not normal cells.
@en
Macrophages activated in vitro ...... oplastic but not normal cells.
@nl
type
label
Macrophages activated in vitro ...... oplastic but not normal cells.
@en
Macrophages activated in vitro ...... oplastic but not normal cells.
@nl
prefLabel
Macrophages activated in vitro ...... oplastic but not normal cells.
@en
Macrophages activated in vitro ...... oplastic but not normal cells.
@nl
P2093
P1476
Macrophages activated in vitro ...... oplastic but not normal cells.
@en
P2093
Churchill WH Jr
Piessens WF
P304
P407
P433
P577
1975-01-01T00:00:00Z